Pulse Biosciences, Inc. PLSE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$18.58M-10.6% | -$17.43M+10.1% | -$19.39M-52.9% | -$19.17M-68.4% | -$16.8M-65.7% | ||
| $88K-24.8% | $93K-23.1% | $100K0.0% | $100K0.0% | $117K-11.4% | ||
| $1.91M-66.3% | $4.97M-26.8% | $5.62M+88.4% | $5.19M+153% | $5.68M+223% | ||
| -$55K— | $259K— | —— | —— | -$0— | ||
| $70K+133% | $79K— | $6K— | $21K— | $30K— | ||
| -$148K-121% | —— | $274K— | $332K+305% | $712K+674% | ||
| $1.83M+160% | -$1.63M-151% | —— | —— | -$3.04M-96.8% | ||
| -$3K-400% | —— | —— | $422K+415% | $1K— | ||
| -$62K— | —— | —— | —— | -$0— | ||
| $167K+0.6% | $166K0.0% | $166K-0.6% | $167K+0.6% | $166K-0.6% | ||
| $308K+12.4% | $306K+20.0% | $291K+26.5% | $282K— | $274K— | ||
| -$375K-16.8% | -$360K-20.4% | -$355K-28.6% | -$332K-30.7% | -$321K-30.0% | ||
| -$14.6M-7.9% | -$14.76M-61.4% | -$13.04M-44.5% | -$12.81M-52.6% | -$13.52M-38.3% | ||
| $33K-26.7% | $105K+98.1% | $62K+63.2% | $103K+255% | $45K+800% | ||
| -$33K+26.7% | -$105K-98.1% | -$62K-63.2% | -$123K-324% | -$45K-800% | ||
| $1.67M+341% | $387K+3.8% | $1.71M+259% | $12K-7.7% | $380K+4,122% | ||
| $2.21M-85.1% | $381K-99.2% | $1.97M-96.8% | $0— | $14.81M+4,755% | ||
| -$12.42M-1,100% | -$14.48M-137% | -$11.14M-121% | -$12.93M-48.8% | $1.24M+113% | ||
| $167K+0.6% | $166K0.0% | $166K-0.6% | $167K+0.6% | $166K-0.6% | ||
| $88K-24.8% | $93K-23.1% | $100K0.0% | $100K0.0% | $117K-11.4% | ||
| -$375K-16.8% | -$360K-20.4% | -$355K-28.6% | -$332K-30.7% | -$321K-30.0% | ||
| $129K-54.1% | $374K— | $115K-63.1% | $142K+59.6% | $281K+4,114% | ||
| $308K+12.4% | $306K+20.0% | $291K+26.5% | $282K— | $274K— | ||
| -$62K— | —— | —— | —— | -$0— | ||
| $57K— | $0-100% | $0— | -$0— | -$0— | ||
| $465K+32.1% | —— | $241K+32.4% | —— | $352K+18.9% | ||
| $130K-99.1% | $20K-100.0% | $17K-98.9% | $0— | $14.08M— | ||
| $28K+7.7% | —— | —— | —— | $26K— | ||
| -$375K-16.8% | -$360K-20.4% | -$355K-28.6% | -$332K-30.7% | -$321K-30.0% | ||
| —— | $0-100% | $0-100% | $0-100% | $0-100% | ||
| $111K— | —— | —— | —— | $0— | ||
| $3K-72.7% | —— | —— | —— | $11K+238% | ||
| $281K— | —— | —— | —— | $0— | ||
| -$14.63M-7.8% | -$14.86M-61.6% | -$13.1M-44.6% | -$12.91M-53.3% | -$13.57M-38.6% | ||
| -$14.63M-7.8% | -$14.86M-61.6% | -$13.1M-44.6% | -$12.91M-53.3% | -$13.57M-38.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Pulse Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.